Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis

Conditions:   Generalized Myasthenia Gravis;   Myasthenia Gravis Interventions:   Drug: ALXN2050;   Drug: Placebo Sponsor:   Alexion Pharmaceuticals Recruiting

Source: ClinicalTrials.gov - February 1, 2022 Category: Research Source Type: clinical trials